Novo Nordisk is seeking a Specialist for CMC Injectable Drug Product Development to take scientific ownership of one drug modality in the pipeline. You will bridge insights across projects and anticipate future formulation challenges, translating molecular innovation into clinical-ready drug products.
What You'll Do
- Lead formulation and small-scale process development activities for one drug modality from early to late phase development (Ph I–III).
- Develop strategies to design, execute, and interpret formulation and stability studies.
- Prepare clear study reports for internal use, patent filings, and regulatory submissions.
- Drive innovation initiatives and propose new formulation strategies or technologies.
- Mentor and guide colleagues and lab staff on experimental approaches and problem solving.
- Collaborate closely with experts in Global Research, Regulatory Affairs, Quality Assurance, and Analytical Development.
What We're Looking For
- PhD or Master’s degree within Pharmaceutical Sciences, Engineering, or another relevant natural science field.
- Minimum 6+ years of working experience within formulation development of peptides, proteins, antibodies, or minibinders.
- In-depth knowledge of working within R&D or drug product development across all phases of development (Ph I-III).
- Demonstrate an innovative, proactive, and engaging mindset to move projects forward and inspire teammates.
- Ability to work independently and with others across a complex stakeholder environment.
- Fluency in written and spoken English.
Team & Environment
You will join our CMC Injectable Drug Product Development department, specifically the CMC Product & Process Development area. The team consists of approximately 100 employees organised into six teams.
Work Mode
This role is onsite in Måløv, Denmark.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
